A Strategic Guide to Capitalizing on Patent Expiry, Generic Entry, and Product Reformulation
In the fiercely competitive world of pharmaceuticals, the expiration of a patent isn’t just a milestone—it’s a pivotal moment that can redefine a company’s trajectory. Yet, many organizations fail to capitalize on this opportunity, leaving significant …
